474 related articles for article (PubMed ID: 11606408)
41. Pattern of expression of CXCR4 and adhesion molecules by human CD34+ cells from different sources: role in homing efficiency in NOD/SCID mice.
Herrera C; Sanchez J; Torres A; Pascual A; Rueda A; Alvarez MA
Haematologica; 2004 Sep; 89(9):1037-45. PubMed ID: 15377464
[TBL] [Abstract][Full Text] [Related]
42. [The effect of matrix metalloproteinase-9 in granulocyte colony stimulation factor-induced stem cell mobilization].
Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2966-70. PubMed ID: 17288807
[TBL] [Abstract][Full Text] [Related]
43. HOX decoy peptide enhances the ex vivo expansion of human umbilical cord blood CD34+ hematopoietic stem cells/hematopoietic progenitor cells.
Tanaka H; Matsumura I; Itoh K; Hatsuyama A; Shikamura M; Satoh Y; Heike T; Nakahata T; Kanakura Y
Stem Cells; 2006 Nov; 24(11):2592-602. PubMed ID: 17071861
[TBL] [Abstract][Full Text] [Related]
44. Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow.
Brunner S; Zaruba MM; Huber B; David R; Vallaster M; Assmann G; Mueller-Hoecker J; Franz WM
Exp Hematol; 2008 Sep; 36(9):1157-66. PubMed ID: 18504066
[TBL] [Abstract][Full Text] [Related]
45. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
[TBL] [Abstract][Full Text] [Related]
46. Human hematopoietic stem/progenitor cells generate CD5+ B lymphoid cells in NOD/SCID mice.
Novelli EM; Ramírez M; Leung W; Civin CI
Stem Cells; 1999; 17(5):242-52. PubMed ID: 10527459
[TBL] [Abstract][Full Text] [Related]
47. Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice.
Davidoff AM; Ng CY; Brown P; Leary MA; Spurbeck WW; Zhou J; Horwitz E; Vanin EF; Nienhuis AW
Clin Cancer Res; 2001 Sep; 7(9):2870-9. PubMed ID: 11555605
[TBL] [Abstract][Full Text] [Related]
48. A subpopulation of malignant CD34+CD138+B7-H1+ plasma cells is present in multiple myeloma patients.
Kuranda K; Berthon C; Dupont C; Wolowiec D; Leleu X; Polakowska R; Jouy N; Quesnel B
Exp Hematol; 2010 Feb; 38(2):124-31. PubMed ID: 19948206
[TBL] [Abstract][Full Text] [Related]
49. Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo.
Ohm JE; Shurin MR; Esche C; Lotze MT; Carbone DP; Gabrilovich DI
J Immunol; 1999 Sep; 163(6):3260-8. PubMed ID: 10477595
[TBL] [Abstract][Full Text] [Related]
50. Biological characterization of stem cell present in mobilized peripheral blood of CML patients.
Tsukamoto AS; Reading C; Carella A; Frassoni F; Gorin C; LaPorte J; Negrin R; Blume K; Cunningham I; Deisseroth A
Bone Marrow Transplant; 1994; 14 Suppl 3():S25-32. PubMed ID: 7535151
[TBL] [Abstract][Full Text] [Related]
51. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation.
Wartiovaara U; Salven P; Mikkola H; Lassila R; Kaukonen J; Joukov V; Orpana A; Ristimäki A; Heikinheimo M; Joensuu H; Alitalo K; Palotie A
Thromb Haemost; 1998 Jul; 80(1):171-5. PubMed ID: 9684805
[TBL] [Abstract][Full Text] [Related]
52. Behavior of CD34+ cells isolated from patients with polycythemia vera in NOD/SCID mice.
Ishii T; Zhao Y; Sozer S; Shi J; Zhang W; Hoffman R; Xu M
Exp Hematol; 2007 Nov; 35(11):1633-40. PubMed ID: 17764815
[TBL] [Abstract][Full Text] [Related]
53. Flow cytometric detection of growth factor receptors in autografts and analysis of growth factor concentrations in autologous stem cell transplantation: possible significance for platelet recovery.
Schiødt I; Jensen CH; Kjaersgaard E; Gaarsdal E; Nikolajsen K; Johnsen HE
Bone Marrow Transplant; 2000 Sep; 26(5):525-31. PubMed ID: 11019842
[TBL] [Abstract][Full Text] [Related]
54. Ex vivo manipulation of hematopoietic stem and progenitor cells.
Kanz L; Brugger W; Scheding S
Stem Cells; 1998; 16 Suppl 1():199-204. PubMed ID: 11012163
[TBL] [Abstract][Full Text] [Related]
55. CXCR-4 expression on bone marrow CD34+ cells prior to mobilization can predict mobilization adequacy in patients with hematologic malignancies.
Dabusti M; Lanza F; Campioni D; Castagnari B; Tieghi A; Moretti S; Punturieri M; De Angeli C; Spanedda R; Ferrazzi E; Castoldi G
J Hematother Stem Cell Res; 2003 Aug; 12(4):425-34. PubMed ID: 12965079
[TBL] [Abstract][Full Text] [Related]
56. Evidence of peripheral blood-derived, plastic-adherent CD34(-/low) hematopoietic stem cell clones with mesenchymal stem cell characteristics.
Huss R; Lange C; Weissinger EM; Kolb HJ; Thalmeier K
Stem Cells; 2000; 18(4):252-60. PubMed ID: 10924091
[TBL] [Abstract][Full Text] [Related]
57. Peripheral blood CD34+ cells: method of purification and ex vivo expansion.
Bohbot A; Feugeas O; Cuillerot JM; Grosse A; Rusciani I; Faradji A; Oberling F
Nouv Rev Fr Hematol (1978); 1995; 37(6):359-65. PubMed ID: 8907632
[TBL] [Abstract][Full Text] [Related]
58. [Cellular therapy for intensification in oncology and hematology: manipulation of peripheral blood stem-cell products].
Douay L
Bull Cancer; 2001 Sep; 88(9):826-32. PubMed ID: 11604353
[TBL] [Abstract][Full Text] [Related]
59. Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood.
Dialynas DP; Shao L; Billman GF; Yu J
Stem Cells; 2001; 19(5):443-52. PubMed ID: 11553853
[TBL] [Abstract][Full Text] [Related]
60. Serum-soluble c-kit levels during mobilization of peripheral blood stem cells correlate with stem cell yield.
Ishiga K; Kawatani T; Tajima F; Omura H; Nanba E; Kawasaki H
Int J Hematol; 2000 Aug; 72(2):186-93. PubMed ID: 11039667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
